Loading clinical trials...

Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma | Clinical Trials | Clareo Health

COMPLETEDNA

Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma

Long-term Comparison of Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma: A Multicenter Retrospective Study

NCT06325787•Chinese PLA General Hospital

View on ClinicalTrials.gov

Summary

To evaluate the clinical outcomes of image-guided thermal ablation versus thyroid lobectomy for the treatment of papillary thyroid microcarcinoma

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. solitary papillary thyroid carcinoma confirmed by fine-needle aspiration or core-needle biopsy;
•2. largest diameter ≤10 mm;
•3. no evidence of extrathyroidal extension( no signs of unsmooth thyroid capsule or involvement of the perithyroidal tissue) on ultrasound;
•4. no evidence of cervical lymph node metastasis on US or neck CT;
•5. no distant metastasis on chest CT;
•6. no history of neck irradiation.

Exclusion Criteria

•(1)aggressive subtype of papillary thyroid microcarcinoma confirmed by biopsy(1); (2)multiple tumors; (3) incomplete data or lost follow-up

Key Dates

Start Date

May 1, 2013

Primary Completion Date

January 31, 2017

Completion Date

January 31, 2024

Last Updated

March 25, 2024

Enrollment

1,021

ACTUAL participants

Conditions

Papillary Thyroid Cancer

Interventions

thyroid lobectomy

PROCEDURE

image-guided thermal ablation

PROCEDURE

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

NCT06316895

Papillary Thyroid Cancer

View study

RECRUITING

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

NCT05024929

Papillary Thyroid CancerPediatric Cancer+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 25, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma

Inclusion Criteria

Exclusion Criteria

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer